Evaluation of the Differential Effects of MK-801 and MMP-2200 on Dopamine Receptor 1- and 2-Agonist-Induced Abnormal Involuntary Movements

Class of 2014 Abstract === Specific Aims: The specific aim of this study was to measure the severity of dopamine receptor 1 (D1R)- and dopamine receptor 2 (D2R)-induced abnormal involuntary movements (AIMs) when administered with the NMDA receptor antagonist MK-801 or opioid glycopeptide MMP-2200....

Full description

Bibliographic Details
Main Authors: So, Lisa, Falk, Torsten, Regan, John
Language:en_US
Published: The University of Arizona. 2014
Subjects:
Online Access:http://hdl.handle.net/10150/614195
http://arizona.openrepository.com/arizona/handle/10150/614195